FALSE000180822000018082202021-08-262021-08-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 26, 2021
_________________________
GoHealth, Inc.
(Exact name of registrant as specified in its charter)
_________________________
Delaware 001-39390 85-0563805
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
214 West Huron St. 60654
Chicago, Illinois
(Address of principal executive offices) (Zip Code)
(312) 386-8200
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
_________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange
on which registered
Class A Common Stock,
$0.0001 par value per share
GOCO The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 26, 2021, Rahm Emanuel, a member of the GoHealth, Inc. (the “Company”) Board of Directors, resigned from the Company’s Board of Directors due to his nomination by President Biden to serve as the Ambassador to Japan. Mr. Emanuel served as a Class I director, a member of the Company’s Compensation Committee and as Chair of the Company’s Nominating and Corporate Governance Committee. Mr. Emanuel’s resignation was not related to any disagreement with the Company on any matter relating to its operations, policies or practices.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GOHEALTH, INC.
Date: August 30, 2021 By: /s/ Brian Farley
Brian Farley
Chief Legal Officer

GoHealth (NASDAQ:GOCO)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more GoHealth Charts.
GoHealth (NASDAQ:GOCO)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more GoHealth Charts.